JUN 11, 2020 7:34 AM PDT

Glowing Chemical Reactions Could Put an End to Bad COVID Tests

WRITTEN BY: Tara Fernandez

Advancements in diagnostic technologies are paving the way for the next generation of ultra-sensitive serological tests — capable of making routine blood tests faster, cheaper, and more accurate than ever before. A collaborative study between researchers at the University of Bologna, together with industry partners Roche and Hitachi, was recently published in Nature Communications, demonstrating the potential of this breakthrough.

Serological diagnostics work by detecting the presence of specific molecules, known as biomarkers, within a patient’s blood sample. Many immunoassays for COVID-19, for instance, indicate that an individual is infected by picking up antibodies against SARS-CoV-2 and, through a series of chemical reactions, create a quantifiable signal. 

One such chemical reaction is a light-emitting mechanism called electrochemiluminescence, or ECL. ECL-based tests are excellent diagnostics as they generally have long shelf lives, can be read in under 20 minutes, and require only tiny volumes of a patient’s blood sample.

Though commonly used, these tests can sometimes fall short in terms of reliability; biomarkers need to reach a certain threshold concentration before they are detectable. The latest developments promise to change that, boosting the sensitivity of ECL-based serological tests by up to 128 percent. This means fewer false negatives and disease being caught at much earlier stages — the weakest link in many currently-available COVID tests.

To achieve this, the team identified a series of novel reactants and imaging techniques to amplify ECL signals and make ECL-based serological tests more efficient. Diagnostic biomarkers would not be limited to measuring levels of antibodies but would also encompass enzymes, proteins, peptides, and hormones, all of which could point to the presence of disease.

Lead researcher at the University of Bologna, Giovanni Valenti commented on the implications of this work, saying, "Our work represents something unprecedented in the field of ECL because it relies on the enhancement of the signal as opposed to the enhancement of the target as it usually happens with enzymatic methods or PCR (Polymerase Chain Reaction)."

"These results pave the way for the development of ultra-sensitive serological tests," Valenti added. 

 

Sources: Technology Networks, Nature Communications


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 28, 2020
Drug Discovery & Development
FDA Approves 5-Minute Coronavirus Test
MAR 28, 2020
FDA Approves 5-Minute Coronavirus Test
In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change th ...
APR 21, 2020
Clinical & Molecular DX
Skin Deep: Handheld Device Sees the Earliest Signs of Cancer
APR 21, 2020
Skin Deep: Handheld Device Sees the Earliest Signs of Cancer
Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater t ...
MAY 12, 2020
Clinical & Molecular DX
Could Catching the Flu Be Linked to an Increased Cancer Risk?
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
JUL 07, 2020
Cardiology
Investigating New Ways to Diagnose a Heart of Bone
JUL 07, 2020
Investigating New Ways to Diagnose a Heart of Bone
Calcific aortic stenosis, or calcific aortic valve disease (CAVD), is a progressive cardiovascular disease where the aor ...
JUL 07, 2020
Clinical & Molecular DX
Throat Swabs Prevent COVID False Negatives
JUL 07, 2020
Throat Swabs Prevent COVID False Negatives
  False-negative results are particularly problematic in containing the spread of COVID-19 — infected individ ...
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
Loading Comments...